Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression.
about
Quantitative assessment of Wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemiaMinimal residual disease in acute myeloid leukaemiaReal-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantationEffect of the microtransplantation of allogeneic hematopoietic stem cells as maintenance therapy for elderly patients with acute leukemia.Peripheral blood WT1 expression predicts relapse in AML patients undergoing allogeneic stem cell transplantation.
P2860
Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Estimation of molecular upper ...... ia patients by WT1 expression.
@en
Estimation of molecular upper ...... ia patients by WT1 expression.
@nl
type
label
Estimation of molecular upper ...... ia patients by WT1 expression.
@en
Estimation of molecular upper ...... ia patients by WT1 expression.
@nl
prefLabel
Estimation of molecular upper ...... ia patients by WT1 expression.
@en
Estimation of molecular upper ...... ia patients by WT1 expression.
@nl
P2093
P2860
P356
P1476
Estimation of molecular upper ...... ia patients by WT1 expression.
@en
P2093
Cedrik Haškovec
Jacqueline Maalaufová-Soukupová
Jana Marková
Jaroslav Polák
Jiří Schwarz
P2860
P304
P356
10.3892/ETM.2011.363
P577
2011-10-11T00:00:00Z